.png){kind=logo}
Congratulations to V Vilgrain (E Van Beers) who just obtained an RHU on targeted radionuclide therapies in digestive cancers by imagomics. Its name is OPERANDI.
-
Vilgrain Valérie
- 01 40 87 58 28
- valerie.vilgrain@aphp.fr
Useful contact
– For recruitment and internship files: rhcom.u1149@inserm.fr
– For your orders : commandes.u1149@inserm.fr
– To request a computer intervention: info.u1149@inserm.fr
– For Health and Safety questions: naima.munoz@inserm.fr
– Website editorial committee: To propose news, events and publications to add to the website: cellcom.u1149@inserm.fr
Our Teams
Congratulations to V. Vilgrain who obtained a RHU named OPERANDI
Cellule d'aide Inserm :
pole-montage.dr-idfcn@inserm.fr
Les dernières publications marquantes
-
Publication date : 11 November 2025 More
EASL Clinical Practice Guidelines on vascular diseases of the liver
J Hepatol.
Authors : Rautou Pierre-Emmanuel Moga Lucile Virginia Hernandez-Gea Walter Ageno Sarwa Darwish Murad Juan-Carlos Garcia-Pagan Maria Guido Valérie McLin Dhiraj Tripathi Vilgrain Valérie European Association for the Study of the Liver
-
Publication date : 09 November 2025 More
Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder
JHEP Reports
Authors : Chloé de Broucker Paradis Valérie Maria Luisa Botero Albuquerque Miguel Payancé Audrey Plessier Aurélie Elkrief Laure Durand François Sophie Hillaire Paul-Emile Zafar Juan Carlos Garcia Pagan Rautou Pierre-Emmanuel
-
Publication date : 06 October 2025 More
Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice
PLoS One.
Authors : Cambier Alexandra Da silva Jennifer Bex-Coudrat Julie Canesi Fanny Lison Lachize Neanne Aurélie Sannier Hélène Mathieu Boedec Erwan Amandine Badie Monteiro Renato